Related Experiment Video
Updated: Aug 9, 2026

Minimally Invasive Endoscopic Intracerebral Hemorrhage Evacuation
Published on: October 15, 2021
Intracranial hemorrhage in coronavirus disease 2019 (COVID-19) patients
Isaac Cheruiyot1,2, Prabjot Sehmi3, Beryl Ominde4
1Department of Human Anatomy, University of Nairobi, Nairobi, Kenya. isaacbmn@outlook.com.
Insights
Intracranial hemorrhage (ICH) occurred in 0.7% of COVID-19 patients, often elderly males with hypertension. This condition, though uncommon, carried a high 48.6% mortality rate, highlighting the need for early risk identification.
Area of Science:
- Neurology
- Infectious Diseases
- Public Health
Background:
- COVID-19 is linked to cerebrovascular events, including ischemic stroke.
- Data on intracranial hemorrhage (ICH) in COVID-19 patients remains limited.
- This review consolidates evidence on ICH occurrence in hospitalized COVID-19 patients.
Purpose of the Study:
- To systematically review and analyze the incidence and characteristics of intracranial hemorrhage (ICH) in patients with COVID-19.
- To consolidate current scientific literature on ICH in the context of COVID-19 infection.
Main Methods:
- A systematic literature search was performed on PubMed and CNKI from November 2019 to August 2020.
- Included studies described intracranial hemorrhage (ICH) in COVID-19 patients.
- Data extraction focused on patient demographics, comorbidities, hemorrhage characteristics, treatment, and outcomes.
Main Results:
- 23 studies reported on 148 COVID-19 patients with ICH; pooled incidence was 0.7%.
- Most affected patients were elderly males (65.8%) with hypertension (54%).
- Intraparenchymal hemorrhage was most common (62.6%); mortality rate was 48.6%.
Conclusions:
- Intracranial hemorrhage (ICH) is an uncommon but serious complication of COVID-19.
- High mortality associated with ICH in COVID-19 patients necessitates early identification of at-risk individuals.
- Comorbidities and anticoagulant use are key factors in patients developing ICH during COVID-19.
Background:
Emerging evidence suggests that a subset of coronavirus disease 2019 (COVID-19) patients may present with or develop cerebrovascular disease during the course of hospitalization. Whereas ischemic stroke in COVID-19 patients has been well described, data on intracranial hemorrhage (ICH) in these patients is still limited. We, therefore, conducted a rapid systematic review of current scientific literature to identify and consolidate evidence of ICH in COVID-19 patients.
Methods:
A systematic search of literature was conducted between November 1, 2019, and August 14, 2020, on PubMed and China National Knowledge Infrastructure (CNKI) to identify eligible studies.
Results:
A total of 23 studies describing ICH in 148 COVID-19 patients were included. The pooled incidence of ICH in COVID-19 patients was 0.7% (95% CI 0.5-0.9), with low levels of inter-study heterogeneity observed (I2 = 33.6%, Cochran's Q = 12.05, p = 0.149). Most of the patients were elderly male patients (65.8%) with comorbidities, the most common being systemic hypertension (54%). Hemorrhage involving multiple cranial compartments was reported in 9.5% of cases. Single compartments were involved in the rest, with intraparenchymal hemorrhage (IPH) being the most common variety (62.6%) and intraventricular hemorrhage (IVH) the least common (1.4%). Half of these patients were on some form of anticoagulation. Overall, the mortality rate in the COVID-19 patients with ICH was about 48.6%.
Conclusion:
Although relatively uncommon among COVID-19 patients, ICH is associated with a high mortality rate. Early identification of patients at risk of developing ICH, particularly with comorbid conditions and on anticoagulant therapy, may be important to improve outcomes.
Related Concept Videos
Hemorrhagic Stroke l: Introduction
Hemorrhagic Stroke ll: Pathophysiology
Brain Abscess l: Introduction
Increased Intracranial Pressure l: Introduction
Increased Intracranial Pressure ll: Pathophysiology
Cerebral Edema ll: Pathophysiology

